The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy
Derya R. Shimshek, Matthias Mueller, Christoph Wiessner et al. · 2010
Read The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy by Derya R. Shimshek, Matthias Mueller, Christoph Wiessner et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010014.txt.
Description
Derya Shimshek, Matthias Mueller, Christoph Wiessner, and co-workers tested a hoped-for Parkinson's treatment in mice in PLOS ONE in 2010. In Parkinson's disease, a protein called alpha-synuclein folds badly and clumps in the brain. Heat-shock proteins help refold proteins or clear them away, so they looked like a natural way to cut that clump load.
The team raised levels of the chaperone HSP70 in a mouse model of alpha-synuclein disease. Their title gives the plain result: HSP70 was not beneficial there. A clear negative finding like that saves other groups time and steers the search toward other routes.
Catalog record
| CREATOR | Derya R. Shimshek, Matthias Mueller, Christoph Wiessner et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010014